Search

everythinglearnresearchcommunity

for

Search:↓

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Taking Propecia might lead to the development of cataracts.

Outside factors like grooming, chemicals, and the environment can damage hair and cause disorders.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Bimatoprost 0.01% effectively and safely improves eyebrow growth.

Microneedling combined with skinbooster effectively treats striae rubrae, with confocal microscopy confirming collagen changes.

Melatonin treatment helps improve skin health in postmenopausal rats.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Finasteride, often used for hair loss, can potentially cause cataracts.

Scalp expansion is an effective way to reconstruct the scalp with good cosmetic outcomes.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.

Combining physical dermabrasion with chemical peeling is more effective for skin treatment than chemical peeling alone.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Low-Level Light Therapy is effective for skin rejuvenation, wound healing, and hair growth, with mild side effects.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.